TaiMed Biologics EBITDA vs. Revenue
| 4147 Stock | TWD 79.90 1.30 1.65% |
For TaiMed Biologics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of TaiMed Biologics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well TaiMed Biologics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between TaiMed Biologics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of TaiMed Biologics over time as well as its relative position and ranking within its peers.
TaiMed |
TaiMed Biologics Revenue vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining TaiMed Biologics's current stock value. Our valuation model uses many indicators to compare TaiMed Biologics value to that of its competitors to determine the firm's financial worth. TaiMed Biologics is number one stock in ebitda category among its peers. It also is the top company in revenue category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the TaiMed Biologics' earnings, one of the primary drivers of an investment's value.TaiMed Revenue vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
TaiMed Biologics |
| = | (306.83 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
TaiMed Biologics |
| = | 413.44 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
TaiMed Revenue vs Competition
TaiMed Biologics is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 9.54 Billion. TaiMed Biologics holds roughly 413.44 Million in revenue claiming about 4% of equities under Health Care industry.
TaiMed Biologics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in TaiMed Biologics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, TaiMed Biologics will eventually generate negative long term returns. The profitability progress is the general direction of TaiMed Biologics' change in net profit over the period of time. It can combine multiple indicators of TaiMed Biologics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
TaiMed Biologics Inc., a biotechnology company, develops health-care products. The company was founded in 2007 and is based in Taipei City, Taiwan. TAIMED BIOLOGICS operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.
TaiMed Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on TaiMed Biologics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of TaiMed Biologics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the TaiMed Biologics' important profitability drivers and their relationship over time.
Use TaiMed Biologics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TaiMed Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TaiMed Biologics will appreciate offsetting losses from the drop in the long position's value.TaiMed Biologics Pair Trading
TaiMed Biologics Pair Trading Analysis
The ability to find closely correlated positions to TaiMed Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TaiMed Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TaiMed Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TaiMed Biologics to buy it.
The correlation of TaiMed Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TaiMed Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TaiMed Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TaiMed Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your TaiMed Biologics position
In addition to having TaiMed Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Steel Works Etc Thematic Idea Now
Steel Works Etc
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Steel Works Etc theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Steel Works Etc Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for TaiMed Stock Analysis
When running TaiMed Biologics' price analysis, check to measure TaiMed Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TaiMed Biologics is operating at the current time. Most of TaiMed Biologics' value examination focuses on studying past and present price action to predict the probability of TaiMed Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TaiMed Biologics' price. Additionally, you may evaluate how the addition of TaiMed Biologics to your portfolios can decrease your overall portfolio volatility.